🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/01/2019 | 69,75 | 71,46 | 69,75 | 71,09 | +1,54% | 2,45% | 13.102.096 |
| 14/01/2019 | 70,89 | 71,03 | 69,75 | 70,01 | -2,04% | 1,80% | 15.669.486 |
| 11/01/2019 | 71,28 | 71,51 | 70,75 | 71,47 | +0,56% | 1,06% | 9.878.029 |
| 10/01/2019 | 72,21 | 72,21 | 70,11 | 71,07 | -1,23% | 2,92% | 19.134.070 |
| 09/01/2019 | 72,41 | 72,81 | 71,87 | 71,96 | -0,76% | 1,30% | 11.916.284 |
| 08/01/2019 | 72,40 | 72,72 | 71,84 | 72,51 | +0,74% | 1,21% | 11.896.686 |
| 07/01/2019 | 72,66 | 72,97 | 71,96 | 71,98 | -1,10% | 1,39% | 15.795.142 |
| 04/01/2019 | 71,32 | 73,00 | 71,22 | 72,78 | +3,01% | 2,49% | 14.753.115 |
| 03/01/2019 | 72,10 | 72,49 | 70,47 | 70,65 | -2,05% | 2,81% | 13.910.628 |
| 02/01/2019 | 71,84 | 72,51 | 71,18 | 72,13 | -1,07% | 1,85% | 15.120.125 |
| 31/12/2018 | 72,35 | 73,19 | 72,19 | 72,91 | +1,38% | 1,37% | 9.687.502 |
| 28/12/2018 | 72,40 | 73,07 | 71,40 | 71,92 | -0,01% | 2,31% | 13.180.696 |
| 27/12/2018 | 69,92 | 71,93 | 69,43 | 71,93 | +1,86% | 3,58% | 13.577.154 |
| 26/12/2018 | 67,72 | 70,64 | 67,72 | 70,61 | +4,01% | 4,31% | 14.074.011 |
| 24/12/2018 | 69,21 | 69,56 | 67,64 | 67,89 | -2,40% | 2,77% | 11.565.833 |
| 21/12/2018 | 69,61 | 71,04 | 68,91 | 69,56 | -0,80% | 3,06% | 37.919.994 |
| 20/12/2018 | 70,09 | 70,73 | 69,31 | 70,12 | -0,38% | 2,03% | 20.321.454 |
| 19/12/2018 | 71,26 | 71,80 | 69,72 | 70,39 | -0,75% | 2,92% | 19.765.594 |
| 18/12/2018 | 72,14 | 72,31 | 70,19 | 70,93 | -1,20% | 2,94% | 16.163.828 |
| 17/12/2018 | 72,49 | 73,37 | 71,43 | 71,78 | -1,63% | 2,67% | 15.831.822 |
| 14/12/2018 | 74,27 | 74,46 | 72,74 | 72,98 | -3,20% | 2,31% | 13.896.375 |
| 13/12/2018 | 74,67 | 75,46 | 74,43 | 75,39 | +1,28% | 1,38% | 11.272.498 |
| 12/12/2018 | 74,21 | 75,15 | 74,16 | 74,44 | +1,17% | 1,34% | 11.219.678 |
| 11/12/2018 | 74,35 | 74,72 | 73,03 | 73,58 | -0,40% | 2,27% | 13.867.660 |
| 10/12/2018 | 73,90 | 74,22 | 72,39 | 73,87 | +0,91% | 2,48% | 16.163.618 |
| 07/12/2018 | 74,64 | 74,71 | 72,61 | 73,21 | -2,11% | 2,81% | 13.228.799 |
| 06/12/2018 | 73,44 | 74,78 | 72,35 | 74,78 | +0,20% | 3,31% | 17.329.518 |
| 04/12/2018 | 75,67 | 76,52 | 74,52 | 74,63 | -1,27% | 2,64% | 15.482.942 |
| 03/12/2018 | 75,88 | 75,94 | 74,69 | 75,59 | -0,15% | 1,63% | 13.183.106 |
| 30/11/2018 | 74,27 | 75,85 | 74,16 | 75,71 | +1,84% | 2,27% | 22.380.669 |